Cefoperazone plus mezlocillin for empiric therapy of febrile cancer patients.

MLA

Jones, P., et al. “Cefoperazone plus Mezlocillin for Empiric Therapy of Febrile Cancer Patients.” The American Journal of Medicine, vol. 85, no. 1A, July 1988, pp. 3–8. EBSCOhost, https://doi.org/10.1016/0002-9343(88)90168-4.

APA

Jones, P., Bodey, G. P., Rolston, K., Fainstein, V., & Riccardi, S. (1988). Cefoperazone plus mezlocillin for empiric therapy of febrile cancer patients. The American Journal of Medicine, 85(1A), 3–8. https://doi.org/10.1016/0002-9343(88)90168-4

Chicago

Jones, P, G P Bodey, K Rolston, V Fainstein, and S Riccardi. 1988. “Cefoperazone plus Mezlocillin for Empiric Therapy of Febrile Cancer Patients.” The American Journal of Medicine 85 (1A): 3–8. doi:10.1016/0002-9343(88)90168-4.